novel coronavirus and other viruses with pandemic potential to replicate in human cells, an advance that may lead to new therapeutics for COVID-19.According to the researchers, including those from the the University of Maryland in the US, these compounds disrupt the functioning of a protein complex inside human cells that are critical for the replication and survival of coronaviruses, including the one that causes COVID-19.The scientists believe the findings, published in the journal PNAS, could lead to the development of new broad-spectrum antiviral drugs that target viruses such as influenza, Ebola and coronaviruses like SARS-CoV-2.They said the compounds can disrupt the SKI protein complex in the human body which regulates various.